Uri Tabori bridges between several scientific fields such as Glioma and Medulloblastoma in his study of Cancer research. His study connects Cancer research and Glioma. He undertakes interdisciplinary study in the fields of Medulloblastoma and Gene through his research. Uri Tabori carries out multidisciplinary research, doing studies in Gene and Epigenetics. Uri Tabori performs multidisciplinary study in the fields of Epigenetics and Genetics via his papers. His Genetics study frequently draws parallels with other fields, such as Germline mutation. Internal medicine is intertwined with Cancer and Cohort in his research. Uri Tabori performs multidisciplinary study in Cancer and DNA methylation in his work. His Cohort study frequently draws connections between adjacent fields such as Internal medicine.
His Internal medicine study frequently links to other fields, such as Cohort. Cohort connects with themes related to Internal medicine in his study. Uri Tabori combines Oncology and Radiation therapy in his studies. His Cancer research study frequently links to related topics such as Glioma. As part of his studies on Glioma, Uri Tabori often connects relevant areas like Cancer research. He combines Gene and Genetics in his research. His Genetics study often links to related topics such as Germline mutation. He combines Germline mutation and Mutation in his studies. Uri Tabori incorporates Mutation and Cancer in his studies.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber;Andrey Korshunov;Xiao Yang Liu;David T.W. Jones.
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers;Caitlin F. Connelly;David Fabrizio.
Genome Medicine (2017)
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
Tobias Rausch;David T.W. Jones;Marc Zapatka;Adrian M. Stütz.
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott;Paul A. Northcott;David J.H. Shih;John Peacock;Livia Garzia.
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M.G. Cavalli;Marc Remke;Marc Remke;Marc Remke;Ladislav Rampasek;John Peacock.
Cancer Cell (2017)
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Eric Bouffet;Valérie Larouche;Brittany B. Campbell;Daniele Merico.
Journal of Clinical Oncology (2016)
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
S. C. Mack;H. Witt;R. M. Piro;L. Gu.
Comprehensive Analysis of Hypermutation in Human Cancer
Brittany B. Campbell;Nicholas Light;David Fabrizio;Matthew Zatzman.
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
Pawel Buczkowicz;Christine Hoeman;Patricia Rakopoulos;Sanja Pajovic.
Nature Genetics (2014)
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Hendrik Witt;Stephen C. Mack;Marina Ryzhova;Sebastian Bender;Sebastian Bender.
Cancer Cell (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: